[IMMUNOBIOLOGIC MODIFICATIONS IN CONVALESCENT TYPHOID FEVER PATIENTS SUBJECTED TO ANTI-TYPHOID VACCINATION ANDT TREATED WITH 4-HYDROXY-19-NORTESTOSTERONE-17-CYCLOPENTYL PROPIONATE].
D000293:Adolescent; D045930:Anabolic Agents; D000917:Antibody Formation; D001797:Blood Protein Electrophoresis; D006384:Hemagglutination; D006386:Hemagglutination Tests; D006801:Humans; D009277:Nandrolone; D011422:Propionates; D013256:Steroids; D045165:Testosterone Congeners; D014435:Typhoid Fever; D014436:Typhoid-Paratyphoid Vaccines; D014611:Vaccination; D005719:gamma-Globulins
D045930:Anabolic Agents; D011422:Propionates; D013256:Steroids; D045165:Testosterone Congeners; D014436:Typhoid-Paratyphoid Vaccines; D005719:gamma-Globulins; D009277:Nandrolone
ADOLESCENCE; ANABOLIC STEROIDS; ANTIBODY FORMATION; BLOOD PROTEIN ELECTROPHORESIS; GAMMA GLOBULIN; HEMAGGLUTINATION; TYPHOID; TYPHOID-PARATYPHOID VACCINES
MODICAZIONI IMMUNOBIOLOGICHE IN CONVALESCENTI D'ILEOTIFO SOTTOPOSTI ALLA VACCINAZIONE ANTITIFICA E TRATTATI CON 4-IDROSSI-19-NORTESTOSTERONE-17-CICLOPENTILPROPIONATO.